Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 7/2020

01-07-2020 | Buprenorphine | Concise Research Report

Substance Use Disorder Treatment Availability Among States Considering Medicaid Work Requirements

Authors: Paul J. Christine, MD, PhD, Renuka Tipirneni, MD, MSc

Published in: Journal of General Internal Medicine | Issue 7/2020

Login to get access

Excerpt

In 2018, the Department of Health and Human Services began inviting state Medicaid reforms to “increase employment and community engagement” among enrollees by requiring work or similar activities as a condition of Medicaid eligibility. As of September 2019, seventeen states have applied for section 1115 Medicaid work requirement waivers, nine of which have been approved (with three currently on hold by federal courts).1 Such programs oblige individuals to complete a specified number of work, job training, job search, or community service hours to maintain Medicaid coverage, with exemptions for pregnant and disabled individuals. …
Literature
1.
2.
3.
4.
5.
6.
Metadata
Title
Substance Use Disorder Treatment Availability Among States Considering Medicaid Work Requirements
Authors
Paul J. Christine, MD, PhD
Renuka Tipirneni, MD, MSc
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 7/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05623-1

Other articles of this Issue 7/2020

Journal of General Internal Medicine 7/2020 Go to the issue

Letter to the Editor

The Fragility Index in HIV/AIDS Trials

Review

Effectiveness of Acute Care Remote Triage Systems: a Systematic Review

Viewpoint

When Advance Directives Collide

Concise Research Report

Women’s Reports of Dense Breast Notification Following Mammography: Findings from the 2015 National Health Interview Survey

Report

Capsule Commentary for Azcarate et al., Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population

Original Research

Advance Care Planning Prior to Death in Older Adults with Hip Fracture
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits